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ABSTRACT: Residential fires are a significant cause for morbidity and mortality in the United States. 
Death is often the result of soot and smoke inhalation causing carbon monoxide (CO) toxicity. The 
approximate lethal level of carboxyhemoglobin (COHb) in healthy adults has been well described. 
However, a significant number of medical examiner cases involve infirmed decedents, often elderly, 
with complex cardiovascular disease burdens. It is well known that death in these cases will occur at 
sublethal levels of COHb; however, increased lethality has been largely documented via anecdotal 
experience and lacks quantification. Fifty-five cases were identified where death resulted from smoke 
and soot inhalation suffered in a residential fire. The control group, with no cardiovascular disease, had 
an age-adjusted mean COHb level of 61.6% at the time of death. Presence of hypertensive 
cardiovascular disease showed a 30% reduction in COHb (age-adjusted mean 43.2%), atherosclerotic 
disease showed a 33% reduction (age-adjusted mean 41.5%), and combined disease presentation 
accounted for 41% reduction (age-adjusted mean 36.3%). When controlling for age, atherosclerotic and 
hypertensive cardiovascular diseases were each associated with statistically significant decreases in 
COHb (p < 0.01). Increasing age was associated with decreased COHb levels at 2.8% per 10 years of life 
(p < 0.01), even when modeled with hypertensive and atherosclerotic disease. These findings carry 
important public health significance, as well as practical significance for the medical examiner when 
interpreting COHb levels in cases of suspected deaths due to smoke and soot inhalation.
KEYWORDS:  carbon monoxide, carboxyhemoglobin, cardiovascular disease, atherosclerosis, 
hypertension, residential fire, forensic pathology, autopsy
Despite continued public safety efforts, residential fires in the United States account for significant 
morbidity and mortality. The Federal Emergency Management Agency (FEMA) and the US Fire 
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resulting in 2,695 deaths and 10,825 injuries, amounting to nearly $7.8 billion dollars in losses. In 
comparison to the preceding 10-year period (2008-2017), there was a 2% increase in fires and 8% 
increase in fire fatalities. Cooking related fires continue to be the leading cause of residential fires (52%) 
accounting for 170 fatalities and an 87% increase in deaths in the last 10-years. Unintentional or 
careless fires accounted for the largest portion of fire fatalities (435 deaths) with a 14% increase over 
the last 10-years.(1)
Previous studies have shown that the relative risk of injury and death in a residential fire is increased in 
men, in those impaired by alcohol or drugs, smokers, those who are disabled, and in the elderly.(2,3) A 
2016 report of fire death from the National Center for Health Statistics and the US Census Bureau 
showed that individuals greater than the age of 55 account for nearly 60% of all fire fatalities and have 
a relative risk of fire death that increases precipitously from 1.1 at age 50 – 54 to 3.4 at ages greater 
than 84 years. 
Fatalities due to residential fires are often due to inhalation of toxic gases with a minor contribution 
from cutaneous thermal injuries.(2,4) Approximately 25% of residential fire fatalities are due to thermal 
injuries alone, without a component of smoke and soot inhalation. Inhalation-related deaths are due to 
a complex mixture of gases and particulate matter volatilized by fire, colloquially referred to as smoke. 
The composition of smoke can vary dramatically depending on the materials that are burned, time from 
ignition, temperature, and oxygen supply.(5,6) However, the predominant toxic gases are consistently 
present, namely carbon monoxide (CO) (Table 1). Carbon monoxide is the major poisonous component 
in smoke produced by wood and polymer fires and is the cause of death is nearly all smoke inhalation-
related deaths in residential fires. Carbon monoxide binds the heme group on hemoglobin, functioning 
as a competitive inhibitor of oxygen binding. Carbon monoxide binds with an affinity greater than 200-
fold that of oxygen, forming carboxyhemoglobin (COHb), and effectively shutting down oxygen 
transport causing profound tissue hypoxia, blocking cellular respiration by binding to cytochrome-c 
oxidase, and resulting in chemical asphyxia and death.(7,8) The degree of carboxyhemoglobinemia is 
dependent on the relative amount of CO in the environment, duration of exposure, and respiratory 
rate. Normal COHb levels are <1%, while urban living and smoking cigarettes can account for up to 
levels of 10 – 15%. Levels above 30% are considered life threatening without intervention and greater 
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Several studies have suggested increased CO poisoning for individuals with cardiovascular disease 
causing death at reported sub-lethal concentrations compared with individuals without cardiovascular 
disease. One large study of greater than 500 fire fatalities found that 60% were due to CO poisoning 
alone, 20% were due to the effects of CO and cardiovascular disease, and only 11% of fatalities were 
due solely to thermal injuries.(9) In addition, it has been observed in both autopsy-based studies and 
studies of living patients that CO exposure can aggravate previously asymptomatic atherosclerotic and 
hypertensive cardiovascular disease, causing ischemic injury.(10–13) A study of living individuals with 
diagnosed angina pectoris found that while healthy adults could easily tolerate 10 – 15% COHb levels, 
individuals with coronary artery disease developed angina at concentrations as low as 2%.(11) Even low 
dose exposure can have significant effects on cardiac function in populations with coronary artery 
disease burdens.(14,15)
Acute myocardial injury is common among individuals exposed to CO.(12,13) A retrospective study of 
230 individuals with moderate to severe CO poisoning found evidence of myocardial ischemia in one-
third of cases.(13) Exposure to levels of 15% COHb is sufficient to cause myocardial infarction in 
individuals with at least moderate cardiovascular disease.(11)
For medical examiners, it can be challenging to reconcile the roles of competing factors in the 
determination of cause and manner of death. Although the role of chronic disease is well known, the 
interplay of fire and disease is difficult to untangle, and a true autopsy-based study of the relationship 
between cardiac co-morbidities and CO poisoning has not been identified in the literature. The ability 
to anticipate the effect of specific cardiovascular findings in relation to CO poisoning may be of great 
benefit when opining the cause and manner of death. 
In order to further characterize the relationship between atherosclerotic and hypertensive 
cardiovascular disease and CO poisoning, COHb level and autopsy findings of decedents who died as a 
result of smoke and soot inhalation in residential fires were examined. It was hypothesized that 
decedents with cardiac comorbidities would have greater susceptibility to CO poisoning, manifesting as 

















This article is protected by copyright. All rights reserved
Cases were obtained using CaseManagerfw™ (QuincyTech, Woodbridge, CT) software system in the 
Wayne County Medical Examiner’s Office. We included cases with complete autopsy examinations of 
individuals whose death was certified as smoke and soot inhalation, in which thermal injuries were not 
deemed to be contributory to the cause of death and were not included in the immediate cause of 
death. Routine histology was not examined in these cases. All cases had COHb levels determined via 
postmortem toxicology. Hydrogen cyanide toxicity was not suspected in any cases and postmortem 
samples were not examined for hydrogen cyanide. Children were excluded from the study. Cases that 
were confounded by additional trauma or other injuries were excluded. There were 55 cases identified 
that met the preceding criteria (from 2007 to 2019). 
Data Collection
The autopsy reports were reviewed for relevant demographic data, cause and manner of death, and 
autopsy findings.  Autopsy reports and postmortem photographs were examined for the presence of 
soot in the airways, severity of thermal injuries, and the presence of cardiovascular disease. 
Cardiovascular disease was recorded as either atherosclerotic or hypertensive. Atherosclerotic disease 
was categorized based on narrowing of the coronary artery diameter by greater than 50% (equivalent 
to 75% luminal stenosis) in any coronary artery.(16) Hypertensive cardiovascular disease was 
categorized based on the presence of cardiomegaly and concentric left ventricular hypertrophy (> 1.5 
cm), in the absence of other explanations for concentric left ventricular hypertrophy.(17) Height and 
weight recorded at the time of death were used to calculate the body mass index (BMI). The heart 
weight recorded at the time of autopsy and BMI were used to identify decedents with cardiomegaly, 
based on parameters previously published.(18,19) Decedents with no cardiovascular disease were 
recorded as controls.
Postmortem toxicology was collected on all cases. Peripheral blood from the iliac vein was used.(20) 
Toxicology prior to 2012 was performed at the toxicology laboratory at the Wayne County Medical 
Examiner’s Office. Toxicology testing after 2012 was submitted to National Medical Services (NMS labs, 
Horsham, PA). Samples were tested for carbon monoxide exposure by quantification of COHb using a 
bio-uptake screen via spectrophotometry (5% reportable limit) and confirmed on gas 
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Individuals were categorized into one of four categories: (1) controls; (2) hypertensive cardiovascular 
disease (HCVD); (3) atherosclerotic cardiovascular disease (ASCVD); and (4) hypertensive and 
atherosclerotic cardiovascular disease (HASCVD). Baseline demographic characteristics and autopsy 
findings for controls and patients with subgroups of cardiovascular pathology were compared. To 
evaluate for possible confounding variables, statistically significant differences between the two groups 
were assessed using a one-way analysis of variance (ANOVA) for continuous variables and a chi-squared 
test for categorical variables.
Variation in COHb level between the four groups was assessed using an analysis of covariance 
(ANCOVA), including age as a covariate and with an a priori alpha of p < 0.05 for statistical significance. 
The ANCOVA subgroups were assessed for normality using visual evaluation of a Q-Q plot and for 
homogeneity of variances using Levene’s test.  Pairwise comparisons between individual groups were 
performed with a Tukey range test with corrected p values. To evaluate the relative roles of age, 
hypertensive cardiovascular disease, and atherosclerotic cardiovascular disease, these three variables 
were modeled together in a multivariate linear regression.
To screen for other possible associations with COHb levels, univariate linear regressions were 
performed with sex, race, BMI, heart weight, and cardiomegaly as independent variables. Because it 
was hypothesized that BMI may have a non-linear (e.g. J-shaped) relationship with COHb levels, BMI 
was grouped into three subgroups and analyzed by one-way ANOVA.
Results
There were 55 cases identified that met criteria for inclusion into the study. Demographically, the mean 
age was 56.0 years, 64% of decedents were men, and 60% were black. The mean heart weight was 430 
grams and 65% had cardiomegaly, as defined by previously published criteria.(18,19) Nearly all of the 
decedents had soot in the airways (96%) and a majority had thermal injuries (78%).
There were 23 decedents (42%) with no cardiovascular disease at autopsy used as controls. Of the 
remaining 22 cases, all decedents had cardiovascular disease confirmed at autopsy. There were 8 (15%) 
cases identified with hypertensive cardiovascular disease (HCVD), 11 (20%) with atherosclerotic 
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By one-way ANOVA analysis, the subgroups of disease significantly differed in age (F(3,51) = 12.6, p < 
0.01) and heart weight (F(3,51 = 14.7, p < 0.01). By chi-squared analysis, cardiomegaly significantly 
differed between groups (p = 0.01) (Table 3). There were no other statistically significant differences 
between subgroups in terms of autopsy findings or demographic characteristics. Because cardiomegaly 
and heart weight were incorporated into our definition of hypertensive cardiovascular disease, only age 
was included as a covariate in further analysis of COHb between subgroups. 
ANCOVA analysis showed statistically significant differences in mean age-adjusted COHb levels between 
subgroups. (F(3, 50) =  16.8, p < 0.01). Mean age-adjusted COHb levels were as follows: in the control 
group, 62% (95% CI = 57% to 66%); in the HCVD group, 43% (95% CI = 36% to 51%); in the ASCVD group, 
42% (95% CI = 35% to 48%); and in the HASCVD group, 36% (95% CI = 30% to 42%). (Figure 1) By 
pairwise adjusted analysis, all groups were significantly lower than normal controls, but did not 
significantly differ among each other. COHb values for the subgroups were normally distributed based 
on visual interpretation of a Q-Q plot and met the assumption of homogeneity of variances based on 
Levene’s test (p = 0.31).
Univariate Linear regression showed no statistically significant association with COHb levels and body 
mass index (BMI). We further subgrouped BMI into three groups: less than 20, 20-30, and greater than 
30. By one-way ANOVA, no statistically significant association was seen between BMI subgroups and 
COHb levels (Figure 2).
When modeled together controlling for the presence of hypertensive cardiovascular disease and 
atherosclerotic cardiovascular disease (independent of specific cardiovascular disease subgroup), 
increasing age showed a linear relationship with decreasing COHb levels (r2 = 0.66), with each 10 years 
of life associated with a 2.8% decrease in COHb levels (95% confidence interval = 0.9% to 4.6%, p < 
0.01) (Table 4). In this model, the presence of hypertensive cardiovascular disease was associated with 
a mean decrease of 11.8% COHb (95% CI = 5.8% to 17.9%), and atherosclerotic cardiovascular disease 
was associated with a mean decrease of 14.8% (95% CI = 7.1% to 22.4%).
Additionally, we performed univariate linear regression to screen for other variables that may be 
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COHb levels and race (p = 0.79), sex (p = 0.44), or cardiomegaly (p = 0.10). A statistically significant 
association was observed between COHb levels and heart weight, but this association did not remain 
after controlling for the presence of hypertensive cardiovascular disease (p = 0.74). When men and 
women who met criteria for cardiomegaly based on BMI were compared with sex-matched controls, 
there was no significant difference identified between the two groups.
Discussion
Residential fire fatalities continue to be a significant cause of death in the United States. Death is 
usually caused by smoke and soot inhalation, with resulting CO poisoning. The association between 
cardiovascular disease and CO poisoning has been shown in various clinical studies to cause angina and 
increase the risk of myocardial infarction.(11),(14,15) Further characterization of the effect of specific 
cardiovascular pathologies, namely atherosclerotic and hypertensive disease, and their effect on fatal 
CO poisoning was lacking. 
Consistent with previous reports, decedents with cardiovascular disease burdens had reduced COHb 
levels at the time of death when compared with controls. All three subgroups of cardiovascular disease 
– HCVD, ASCVD, and HASCVD – showed significant decreases in age-adjusted COHb levels compared 
with controls.  These findings are consistent with previous literature establishing that patients with 
atherosclerotic and hypertensive cardiovascular disease show increased vulnerability to CO 
poisoning.(11,14,21)
BMI, which has repeatedly been shown to be a reliable health indicator for cardiometabolic risk 
factors(22) such as hypertension, hypercholesterolemia, and inflammation, was not associated with 
decreased COHb levels. In addition, cardiomegaly and heart weight were not independently associated 
with decreased COHb levels once hypertensive disease controlled. These findings further support the 
unique role for hypertensive and atherosclerotic disease – rather than measures of overall 
cardiometabolic health – in increasing the risk of fatal CO poisoning.
The strong association between increased age and decreased postmortem COHb levels strongly 
supports the substantial vulnerability of elderly individuals. Previous literature has shown that the 
elderly are at increased risk of death due to residential fire, and the findings in this study show that 
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risk factors being debility/disability hindering any potential evacuation of hazardous environments. 
(2,3) 
However, our multivariate analysis shows a striking predominance for the impact of cardiovascular 
disease when compared with the impact of age. The impact of age, likely due to the cumulative effect 
of degenerative vascular and organ disease, was equivalent to a reduction of COHb concentration of 
~2.8% per decade of life. The analysis shows that the presence of hypertensive disease is the risk 
equivalent to ~42 additional years of life. The presence of atherosclerotic disease is the risk equivalent 
to ~53 additional years of life.  For example, a 90 year old healthy decedent would be expected to have 
roughly the same fatal COHb level as a 48 year old decedent with hypertensive cardiovascular disease 
or a 37 year old decedent with significant atherosclerosis. 
Nonetheless, age is a complex factor. The fact that increasing age is associated with decreased COHb 
levels, independent of cardiovascular disease, suggests that other age-related factors play a smaller 
role in CO poisoning.  These factors may include other co-morbid conditions, including those affecting 
renal, hepatic, and pulmonary function, limitations on physical activity, or limited ability to function 
independently. The role of confounding parameters was not evaluated in this study. Our findings show 
that age and cardiac comorbidities account for a majority of the variability in CoHb levels. The precise 
degree to which other comorbidities may affect COHb levels remains undefined. Based on the findings 
of our multivariate regression, up to 34% of the variation in COHb is not explained by the variables that 
were assessed. For example, pulmonary disease (e.g. chronic obstructive pulmonary disease) may 
contribute to a reduced COHb level, but was not assessed in this study.
The findings here carry important practical significance for the medical examiner as well as important 
public health implications. The effect of cardiovascular disease on fire fatality is significant, and it 
accounts for significantly lower levels of COHb observed at autopsy and postmortem toxicology. When 
significant disease is not identified in the setting of sub-lethal COHb, the contribution of senescence 
should be considered with care and other factors (such as exposure to hydrogen cyanide, another toxic 
smoke product) should be investigated. While our study did not evaluate the role of hydrogen cyanide, 
further research could explore the relationship between hydrogen cyanide toxicity, cardiovascular 
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recognize that commonly cited figures of fatal COHb levels will likely not be applicable when decedents 
have significant underlying cardiovascular disease. 
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Toxic Gas Common Sources
Carbon monoxide (CO) Organic Material
Nitrogen dioxide Wood
Hydrogen chloride Plastics
Hydrogen cyanide Wool, silk, nylons, polyurethane, rubber
Benzene Petroleum products
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TABLE 1—Toxic gas components of wood and polymer smoke. Smoke is a complex mixture of gases, 
many of which are toxic. (23) Toxic gases are categorized as either asphyxiants, such as CO or 
hydrogen cyanide, or as irritants such as hydrogen chloride or nitrogen dioxide.
COHb level (%) Symptoms
0 - 10% Well tolerated, minimal effects
10 - 30% Visual impairment, headache, palpitation, dyspnea
30 - 50% Somnolence, unconsciousness, life threatening
>50% Coma, imminent death
TABLE 2—Carbon monoxide toxicity based on carboxyhemoglobin level. Severe poisoning by CO results 
in marked hypotension and lethal arrhythmias, which have been considered responsible for the 
majority of fire deaths. Adapted from Carbon Monoxide Acute Exposure Guideline Levels. In: Acute 
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All cases Controls HCVD ASCVD HASCVD p-value
Number of cases 55 23 8 11 13
Demographics
  Age, mean (yrs) ± SD 56.0 ± 19.4 46.0 ± 17.2 43.4 ± 11.4 71.6 ± 16.6 68.2 ± 12.4 < 0.01
  Male (%) 35 (64) 15 (65) 7 (88) 6 (55) 7 (54) 0.40
  Black (%) 33 (60) 15 (65) 4 (50) 8 (73) 6 (46) 0.56
Autopsy Findings
  Mean % COHb ± SD 48.9 ± 17.4 64.4 ± 10.8 46.8 ± 15.9 37.2 ± 9.3 32.8 ± 8.0 < 0.01
  BMI ± SD 25.8 ± 7.3 24.7 ± 6.1 28.7 ± 9.7 24.5 ± 8.1 27.2 ± 7.3 0.59
  Heart weight, mean (grams) ± SD 430 ± 121 359 ± 54 525 ± 88 366 ± 62 550 ± 132 < 0.01
  Cardiomegaly (%) 36 (65) 11 (48) 6 (75) 6 (75) 13 (100) 0.01
  Soot in the airway (%) 53 (96) 22 (96) 8 (100) 10 (91) 13 (100) 0.62
  Thermal injury (%) 43 (78) 19 (83) 6 (75) 6 (55) 12 (92) 0.14
 
HCVD = Hypertensive cardiovascular disease; ASCVD = Atherosclerotic cardiovascular disease; HASCVD = Hypertensive and atherosclerotic 
cardiovascular disease
TABLE 3—Baseline demographic characteristics and autopsy findings for controls and decedents with cardiovascular disease. Statistical 
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Factor  Reduction in COHb level (%) 95% CI (%)
10 years of age -2.8 -0.9 to -4.7
HCVD -11.8 -5.7 to -17.9
ASCVD -14.8 -7.1 to -22.4
    
TABLE 4—Relative contributions of age, hypertensive cardiovascular disease, and atherosclerotic 
cardiovascular disease to carboxyhemoglobin level. All values were obtained using multivariate linear 
regression with carboxyhemoglobin (COHb) as the dependent variable.
 
Figure Legends
FIG. 1—Association between carboxyhemoglobin level and cardiovascular disease. Comparison of COHb 
levels between cardiovascular disease subgroups using an ANCOVA analysis with age as a covariate 
showed a significant difference between groups. (F(3, 50) =  16.8, p < 0.01). Pairwise comparisons 
between groups were performed by post-hoc testing with Tukey correction.  
HCVD = Hypertensive cardiovascular disease; ASCVD = Atherosclerotic cardiovascular disease; HASCVD = 
Hypertensive and atherosclerotic cardiovascular disease
FIG. 2—Association between body mass index and carboxyhemoglobin level. No statistically significant 
association between BMI and COHb level was seen either in linear regression (p = 0.58) or when stratified 
















 Normal HCVD ASCVD HASCVD 
Number of cases  23 8 11 13 
Unadjusted mean COHb (%) 64.4 46.8 37.2 32.8 
Standard devia on 10.8 15.9 9.2 8.0 
Age-adjusted mean COHb (%) 61.6 43.2 41.5 36.3 
P-Values     
vs. Normal  <0.01 <0.01 <0.01 
HCVD vs HACVD  0.52  0.52 
CVD  
 

















 BMI < 20 BMI 20 – 30 BMI > 30 
Number of cases 15 26 14 
Mean COHb (%) 49.5 50.6 41.2 
Standard devia on 15.4 18.46 18.0 
    
P-values (vs BMI 20 – 30)  0.85   0.17 
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